KEY NOTE SPEAKERS

  • Anna Prokůpková

    Policy & Project Officer

    Association of European Cancer Leagues (ECL)

  • Axel Boehnke

    Director Market Access Europe North

    PTC Therapeutics

  • Johan Holmström

    Global Pricing and Market Intelligence, Dental Implants

    Dentsply Sirona

  • Jörg Mahlich

    Head of Health Economics and Outcomes Research

    Janssen pharmaceutical

  • Ryotaro Ishikawa

    Global Market Access Director

    Novartis

  • Santiago Moreno

    Senior HEOR Manager

    Servier

  • Sebastian Gensior

    Managing Director

    Global Health Access Solutions

  • Alan Crowther

    General Manager, Global Pricing & Access

    Eversana

  • Ruven Remo Eul

    Director, Life Sciences

    HighPoint Solutions

  • Fabrizio Gianfrate

    Professor of Health Economics

    University of Ferrara, Luiss Business School Rome, Italy

  • George Boretos

    CMO

    Cube RM

  • Sandra Garitonandía

    Business Development Manager for Life Sciences

    Vistex EMEA

  • Magdi Stino, MBA,MS,PhD

    Product Manager

    EVERSANA

  • Muge Gurevin

    TWAL Tender & Pricing Manager

    MEDTRONIC

  • Stefan Krojer

    Head of Strategic Procurement

    Johanniter Competence Center GmbH

  • Antoine Jouineau

    Director, Commercial Operations and Pricing

    EMEA, ABBOTT RAPID DIAGNOSTICS

  • Josh Bedel

    Sr. Director Pricing and Market Access

    Clovis Oncology

 

Pricing in a complex ecosystem  

dealing with transparency, collaborative relationships and smart data

 

The 9th annual EPP Life Sciences Pricing Forum will provide you with the latest knowledge on pricing trends, industry best-practices and will equip you with the tools necessary to empower your success. The theme of the forum will orbit around: Pricing in a complex ecosystem – dealing with transparency, collaborative relationships and smart data.

Our forum will enable you to make connections with over 100 industry leaders, share pioneering content and discuss the latest practices impacting pricing in the complex Life Sciences’ ecosystem. We will discuss new pricing strategy, effective collaboration with payers and other stakeholders, usage of data and technology to optimise pricing strategy, market access models, price policy and innovative pricing tools.

You will get access to exclusive content, 15+ expert presentations, 10+ case studies, 4+ workshops, 2+ Roundtable discussions, 2+ panel sessions and an incredible and entertaining evening event tailored to facilitate networking between Life Sciences industry leaders!

 

If you would like to share your knowledge on this upcoming forum, please contact our Conference Producer: camila.rios@pricingplatform.eu

or our Learning Development & Partner Relationships Manager: britt.dejager@pricingplatform.eu

You can also reach us at: +32(0)473.71.76.69

Pre-order the brochure now and have it sent to you as soon as it is ready. Just fill in your details when clicking the download brochure button.

 

 

 

Are you an influencer or specialized in pricing based on AI, machine learning – or agile pricing strategies in a digital world? we want to hear from you !

If you would like to contribute to this unique forum,
please contact Camila Rios at Camila.rios@pricingplatform.eu

         

The 8th EPP Life Sciences Pricing Forum was a big success in 2018!
Relive it now.


If you would like to be part of this amazing forum next year : please contact us:
camila.rios@pricingplatform.eu or  britt.dejager@pricingplatform.eu or just give us call +32(0)473.71.76.69 


5 reasons why you should attend the EPP Life Sciences Pricing Forum in 2019 

  1. You will acquire the latest knowledge on pricing trends, industry best-practices and the tools necessary to empower your success.
  2. 100+ senior industry leaders come together for exclusive keynote presentations, innovative workshops, breakouts on Pharma and MedTech, roundtable discussions and unrivaled networking to engage in high level discussions that will shape the future of pricing and market access in Life Sciences
  3. The forum agenda is created together with key industry influencers to include the most relevant and up-to-date content
  4. 18+ Speakers delivering interactive workshops, roundtables, panel discussions and ground-breaking presentation
  5. Pharma & MedTech Breakouts: Discuss, learn and challenge both strategic and tactical topic

Who will be attending?

Every year 100+ medtech and pharma industry delegates gather to discuss and reflect on the latest pricing and market access trends. The goal is to provide you with knowledge about best business practices and offer you a chance to meet world’s best experts in pricing and profit optimisation.

The EPP Life Sciences Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for key stakeholders such as: Pricing, Reimbursement, Market Access, Commercial, Marketing and Sales Directors and VPs, CEOs and General Managers.

Please do not hesitate to contact us if you would like to get more information: camila.rios@pricingplatform.eu 

 


 

This is an event you must attend!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

THE PROGRAMME

We are working on the upcoming program 2019.

If you want to keep updated, please request the brochure (see top right in navigation).  As soon as the new brochure is available, we will send you the program !

14 Oct
13.00-15.30
WS 1: Pricing and Valuing Digital Therapies Magdi Stino, MBA,MS,PhD - EVERSANA



14 Oct
16.00-18.30
WS 2: Beyond Price Management: A 3-step Guide to Boost your Margin PHARMA + MEDICAL DEVICES Sandra Garitonandía - Vistex EMEA



October 15th 2019
Session 1: Staying relevant in the complex pricing ecosystem ------------------------------------------- - -------------------------------------------
Welcome by EPP President Pol Vanaerde - President - European Pricing Platform (EPP)
9.10 Audience Polling - through EPP Mobile App
9.15 Chairman’s Opening Remarks tbd
9.20 Innovative Hospital Procurement meets Supplier Collaboration Stefan Krojer, Head of Strategic Procurement - JOHANNITER COMPETENCE CENTER GmbH

• Listen about the future of hospital procurement and its implications
• Understand how hospitals and suppliers can collaborate in this scenario
• Explore this with real cases and success stories

9.55 Towards the inevitable: health products in the age of price transparency Anna Prokupkova, Policy & Project Officer - ASSOCIATION OF EUROPEAN CANCER LEAGUES (ECL)
  • Global push for pricing transparency – state of play – what next after WHA Resolution?
  • EU Member States’ action and the potential of join procurement initiatives and EURIPID in pricing negotiations and information sharing
  • The potential impact of increasing price transparency on sustainable patient access to medicines, vaccines and other health products
10.30 What happens to prices after they are set by the industry
  • Listen from one of the biggest retailers in Central Europe and understand what happens to prices after they are set by the industry
  • Understand the approach of Dr.Max and the role of their pricing strategy in becoming the country’s leading healthcare retailer
11.05 Coffee Break and Networking
11.35 Interactive Panel Session: Understanding the implications of an increasingly transparent and interconnected environment
  • Understand how consolidation and acquisition of private and public institutions is impacting the industry and increasing transparency and communication between parties
  • How can you drive collaboration between parties and unite all healthcare stakeholders
12.10 Breakout Session
PHARMA MEDTECH
Decrypting the differential pricing concept and pricing regulations in the US and its impact in EU

  • The proposed Part B IPI regulation and its impact for EU
  • Understand the differential pricing effects in US vs. EU vs. ROW and what can we learn from these findings of differential pricing
  • Explore different strategies to follow to approach different market scenarios to ‘protect pricing’ in EU and US and what implications will the industry face as a result.

Richard Rahul, Senior Manager, MONITOR DELOITTE BELGIUM

Marc Abels, Partner, MONITOR DELOITTE BELGIUM

The pathway towards a more sustainable healthcare system

  • Understand the current increasingly-challenging European situation, dilemmas, certainties and actions to take
  • Forecast of the healthcare system and potential actions to take to increase sustainability through innovative pricing strategies
  • The trend towards refurbished medical technology material, what does this mean for the industry?

 

12.45 Lunch & Networking

Audience Polling Lunch – Join the group with the same topic of interest to discuss over lunch and enjoy casually chatting with other industry players over a delicious lunch.

Session 2 · Innovative Pricing Models in Life Sciences ------------------------------------------- - -------------------------------------------
13.45 Contracting Innovation: What other industries are doing and what can we learn from them Ryotaro Ishikawa, MD MBA, Global Market Access Director - NOVARTIS

• Learn how to communicate cost effectiveness, efficiency and added value of different therapies
• Hear about other industries as inspiration on how to be tested within our industry
• Explore two models: The Subscription Economy and The Power of the Hour Model

14.20 Applying innovative insurance solutions to help future proof healthcare systems Sebastian Gensior, Managing Director - GLOBAL HEALTH ACCESS SOLUTIONS
  • Understanding the current public health systems challenges to fund future high-price medicines
  • Explore innovative insurance solutions to allow higher penetration of this strategy and tackle the issue
  • Discuss how learning from the financial sector can disrupt healthcare insurance via a sandbox approach
14.55 The Economics of Value
  • This presentation outlays the concept of value from an economics perspective
  • Learn how concepts such as willingness to pay, value based pricing, or welfare can be applied to the healthcare market
15.30 The Transaction Price Opportunity: A Guide to Maximize its Value Sandra (Alejandra) Garitonandía Puig, EMEA LifeSciences Manager - VISTEX
  • List Price vs Net Price: When you analyse your Gross-to-Net, do you know which pricing elements matter?
  • Learn how to define and gain control of the transaction price in the most effective way
  • Explore possibilities that a strategic view of Gross-to-Net can bring you
16.10 Coffee Break and Networking
16.40 Break-out
PHARMA MEDTECH
A pragmatic approach to outcome-based pricing in Gene Therapies

  • HTA initiatives to value expensive drugs[i.e. cost effectiveness, relative effectiveness]
  • Innovative reimbursement models for specialty products[i.e. pay for performance, risk sharing, value-based pricing, coverage with evidence development]
  • Case studies of implementation in Gene and Cell Therapies so far

Axel Boehnkle, Director Market Access, EU North, PTC THERAPEUTICS

Case Study: Stop selling products, start selling solutions – Maximize your value proposition through innovative bundles

  • Understand your market and the customers’ needs and explore what new business opportunities your current product portfolio can offer
  • Building a pricing strategy that allows you to charge a premium price for a bundle instead of applying volume discounts
  • Solution selling – a shift in mindset for you and your sales team. Main challenges and how to overcome the hurdles.

 

Johan Holmströrm, Manager Global Pricing and Market Intelligence, DENTSPLY SIRONA IMPLANTS

Case Study: The role of Cost-Effective Analysis in incentivizing innovation to derive an appropriate price for innovative drugs

  • In depth analysis of current conventional CEA for reimbursement decisions landscape causes, consequences and potential solutions
  • Learn an approach to value-based pricing aligning the incentives for innovation with the needs of patients with examples
  • Conclusions of case study

Santiago G. Moreno, Senior Manager of HEOR, SERVIER

Case Study: Tendering & pricing innovation in action “Outside-In”

  • Learn how to take the lead in business model innovation
  • Understand how to succesfully adopt key strategies to deliver great results year after year
  • Hear about a real case study to showcase these strategies

 

Muge Gurevin, Senior Tender, Deal Desk & Pricing Manager, MEDTRONIC

Interactive Campfire Storytelling Session

 Be ready to share your own pricing experiences with others!

Be ready to discuss the topics covered in the conference so far, and how you plan to use the knowledge gained into your role.

 Interactive Campfire Storytelling Session Be ready to share your own pricing experiences with others!

Be ready to discuss the topics covered in the conference so far, and how you plan to use the knowledge gained into your role.

 

18.30 Closing Remarks of the Chairman
October 16th 2019
Technology, SmartData and AI changing the pricing function in Life Sciences ------------------------------------------- - -------------------------------------------
9.00 Chairman’s Opening Remarks Axel Boehnke, Director Market Access, EU North - PTC THERAPEUTICS
9.00 Automatic Tender Discovery using Natural Language Processing and Machine Learning George Boretos, Chief Marketing Officer - CUBE RM
  • Learn how you can use advanced technologies, like Natural Language Processing to automatically discover thousands of Public Tenders across Europe that are relevant to your business.
  • Automatically qualify tenders (Bid/No Bid guidance) leveraging historical information, information coming from online tender sources, and machine learning.
  • Plan ahead for tenders not yet published using machine learning, tender seasonality, and product life cycle.
9.45 Analyzing and Predicting the trade-offs between reimbursement, price, and time-to-market Dr. Magdi Stino, MBA, MS, Phd, Product Manager - EVERSANA

• Conceptual framework for looking at factors that influence reimbursement decisions for HTAs in EMA markets
• Review different approaches to modeling and predicting such topics as time-to-market, price, and access tradeoffs post-EMA authorization
• Discuss how HTA decisions may impact subsequent price trends

10.30 Coffee Break and Networking
11.00
PHARMA MEDTECH
Case Study: Data as the backbone for value-based pricing

  • Explore why data is the most important tool for successful value-based pricing implementation
  • Understand how applying data from the real world can define relevant contracts
  • Learn how to connect different data sources

 

Expectations vs. Reality for pricing the multi-indication oncology drugs

  • Challenges and opportunities when setting correct pricing strategy for multi-indication oncology drugs within an uncertain and fast-evolving competitive landscape.
  • Are innovative pricing schemes and data analytics sufficient to stay compliant to the pricing strategy at the execution stage?
  • Case studies from innovative oncology drugs.

 

Assessing Data Sources for medicine price studies with the Pharmaceutical Pricing and Reimbursement Policies, a WHO Collaborating Centre

  • Learn how to assess the feasibility of medicine price data sources
  • Explore a framework to guide the selection of most appropriate price data sources for pharmacoeconomic research

Hear the results and the conclusions of the study to guide you into the correct selection of data sources for medicine price studies

Using transactional data to clearly define customer groups and optimize pricing

  • Understand how using data to comprehend customer trends and buying behaviour can build a strong pricing strategy
  • Comprehend the Usage of Breakeven and Price Dispersion to find the optimal price points for each segment
  • Listen to applicable learnings for pricing strategy optimization
Roundtables Discussions

  • Applying technology to reduce pricing cycle process
  • Sharing of best practices of technology application to the pricing strategy
  • Using SmartData to demonstrate the value of your product effectively
Roundtables Discussion

  • Applying technology to reduce pricing cycle process
  • Sharing of best practices of technology application to the pricing strategy
  • Using SmartData to demonstrate the value of your product effectively

 

12.45 Lunch & Networking (1 hour)
Session 4: Staying relevant in the complex pricing ecosystem ------------------------------------------- - -------------------------------------------
13.45 Integration of Value Based Pricing in the governance process Antoine Jouineau, Director, Commercial Operations and Pricing – EMEA - ABBOTT RAPID DIAGNOSTICS
  • Explore a methodology: valorise the key differentiators based on the evidence applied in relevant context (segment or geography)
  • Attend a demonstration: simple calculators, online or via apps, easy to use
  • Learn how to Integrate this in the sales process, from strategic selling to pricing governance
14.30 Driving and enhancing the value and visibility of the pricing function through successful and effective collaboration with the sales and marketing teams Pavel Slanina, Strategic Pricing Manager - ZENTIVA
  • Why we need to evolve our communication and way of working to keep the attention of the marketing and sales teams
  • Practical take-away tips and tricks based on real-life examples from my practice working on price increase projects across Europe.
  • Case study highlighting what can be achieved
15.05 Evolution of the drug price in a global increasing challenging reimbursement scenario Prof. Fabrizio Gianfrate, Full-time Professor of Health Economics - UNIVERSITY OF FERRARA

• Understand the pressing drivers impacting the reimbursement landscape
• Get a view of the potential companies’ strategies to react to the changes
• New pricing and reimbursement model and win win potential solutions

15.35 Inspirational Closing
16.20 Closing remarks of the Chairman & President Axel Boehnke, Director Market Access, EU North - PTC THERAPEUTICS

Contact Forum Producer

Camila Rios

PRE FORUM WORKSHOPS

Interested in delivering a Workshop ?

This can be your space to tell the industry about your innovative solutions and products.
Contact Camila Rios, e: Camila.rios@pricingplatform.eu

WS 1: Pricing and Valuing Digital Therapies

14Oct13.00-15.30

Digital therapies are an exciting new area for innovation, as digital diagnostics and digital therapies provide significant new areas of value in healthcare. Companies like Foundation Medicine, Cognoa, Pear Therapeutics, and others are created outcomes-oriented software-driven digital diagnostics and therapies for patients, hospitals and payers that change health outcomes. Meanwhile, many digital devices have their own ecosystem of health information, like continuous glucose monitoring, that can impact health, and further non-traditional healthcare companies like Apple, Google and others enter into this space with consumer devices like the Apple Watch with its ECG capabilities.

 

  • Understand how these therapies get valued, priced and reimbursed
  • Explore what monetization models should all health manufacturers be aware of as they look to extend their own products with a broader software ecosystems strategy
  • Learn how to evaluate this important and growing space

Magdi Stino, MBA,MS,PhD () EVERSANA

WS 2: Beyond Price Management: A 3-step Guide to Boost your Margin PHARMA + MEDICAL DEVICES

14Oct16.00-18.30

During this workshop, we will analyse how to boost the sales margin by making corrections on the revenue leakages side and how to increase sales profit or generate new sources of revenue.

  • Understand the different levels of Revenue Management Strategy beyond “Price” in an interactive workshop with various examples and exercises which will provide you with an innovative perspective and take-aways that can be quickly applied to optimise this process.
  • Learn about Margin Management- or the ability to understand where money is made and lost in your business and how to get the company’s full control and visibility to boost your margin.

Sandra Garitonandía () Vistex EMEA

KEY NOTE SPEAKERS

If you would like to join the speaker faculty, please contact Camila Rios : Camila.rios@pricingplatform.eu

Anna Prokůpková

Policy & Project Officer

Association of European Cancer Leagues (ECL)

Anna is a Policy & Project Officer at the Association of European Cancer Leagues (ECL) responsible for advocacy in the areas of equal access to cancer treatments and patient support. With the ECL Access to Medicines Task Force, Anna works on affordability, fair pricing, and accessibility of cancer medicines. Increased collaboration between European countries in pricing and reimbursement and transparency in medicines prices are key focus of her work. Anna also acts as a liaison for the MEPs Against Cancer (MAC) Interest Group at the European Parliament. Outside of ECL, Anna is a member of the Alliance for responsible R&D and Affordable Medicines, ESMO Patient Advocacy network, Young Gasteiners programme and the European Health Parliament.

Axel Boehnke

Director Market Access Europe North

PTC Therapeutics

Axel Boehnke is a Health Economist, with a master’s degree on Health and Medical Management, currentlyresponsible for EU North as Director Market Access at PTC Therapeutics. Working in pharmaceutical industry for over 15 years allowed him to develop a strong market access skill set with proven track record, executed in Oncology, Autoimmune Diseases, (Ultra) Orphan Diseases, Hepatology, anti-virals, from Humira-franchise business at Abbott, in Servier and deep diverse Biotech Experience. He is a member of the Germany Society of Market Access and the German Society of Health Economics. Before joining the industry, he worked on a German payer organisation.

Johan Holmström

Global Pricing and Market Intelligence, Dental Implants

Dentsply Sirona

Johan Holmström has long and broad experience from leading innovations in various roles in product development, marketing and pricing management. He is currently heading up a team responsible for global strategic pricing of a portfolio with hardware products, software solutions and services. In this role he is leading market intelligence and pricing strategies but also activities to turn them into sustainable business through innovative go-to market and commercialization models.

Johan holds a MSc in engineering from the Royal Institute of Technology, Stockholm and has continued his lifelong learning with additional studies in marketing and business administration.

Jörg Mahlich

Head of Health Economics and Outcomes Research

Janssen pharmaceutical

Jörg Mahlich is head of Health Economics and Outcomes Research at Janssen pharmaceutical companies of Johnson and Johnson in Germany. In addition, he is lecturer of Health Economics at the Economics Department of the University of Vienna and research affiliate at the Düsseldorf Institute for Competition Economics (DICE) of the University of Düsseldorf, Germany. Previous to that he hold different positions in industry and consulting in Austria, Germany, and Japan. He is interested in global pharmaceutical economics and policy. Jörg graduated in economics from the University of Kiel, Germany and holds a doctoral degree in economics from the University of Vienna, Austria.

Ryotaro Ishikawa

Global Market Access Director

Novartis

Ryotaro Ishikawa, MD MBA, with more than 20 years of experience in healthcare industry, is dedicated to test and trial innovative solutions for customers, patients and stakeholder in different geographies. International executive passionate about building high performance teams in Marketing and Sales, Market Access, HEOR in emerging markets.

Experienced in driving value/evidence generation strategy within a cross-functional matrix for HTA Markets including Europe, Latin-America and Asia.

 

Santiago Moreno

Senior HEOR Manager

Servier

Santiago Moreno is an HEOR/HTA professional with +10 years’ experience in the industry and public sector. Over the past decade, Santiago has held various HEOR/HTA positions, most notable at Novartis and Roche. In his current position, Santiago is responsible for leading the Global HEOR/HTA strategy of the oncology franchise at Servier (Paris). His primary focus is ensuring that the evidence package best supports affiliates in their pricing and reimbursement negotiations. Recently, he led the first Novartis submission to EUnetHTA (Rydapt®) and published a number of policy proposals in HTA/payer topics. Santiago holds a Phd in Medical statistics (University of Leicester,UK).

Sebastian Gensior

Managing Director

Global Health Access Solutions

Sebastian is the managing director of Global Health Access Solutions, where he provides clients with market insights and go-to-market strategies. Over the past seven years, he held multiple market access and health policy positions in the pharmaceutical industry, most notably at Roche and Edelman. He has supported pharmaceutical and medical devices clients in understanding healthcare markets around the world and was actively involved in healthcare reforms. Sebastian is constantly exploring innovative pricing and insurance solutions and bringing them to the market.

 

He holds a Bachelor in European Public Health from the University of Maastricht.

 

Alan Crowther

General Manager, Global Pricing & Access

Eversana

Alan Crowther is President of Global Markets of Alliance Life Sciences, responsible for overseeing the Global Pricing solutions for Alliance. He brings 20 years of leadership, consulting and technology experience with him to the position. Alan has previously held roles as CEO at Alliance; founder of Adjility Health, a firm focused on life sciences analytical software; Vice President at Capgemini; Co-founder and Officer at Adjoined Consulting, where he ran the Life Sciences practice and was part of the leadership of the venture-backed company and helped drive it to a successful $200MM+ exit. Prior to Adjoined, Mr. Crowther was head of services for a small software company that exited to BEA Systems; and was a manager at Andersen Consulting (Accenture) before that. He is a graduate of Princeton University.

 

Ruven Remo Eul

Director, Life Sciences

HighPoint Solutions

Ruven is a Director within the European Life Sciences team based out of Zug, Switzerland responsible for project oversight and delivery, resource management and solution development in the areas of Pricing, Contracting and Tendering. Ruven brings a background of industry experiences in large pharma from companies such as Pfizer and BMS where he worked in Commercial roles with a large focus on leading cross functional Tendering teams for Pfizer in Germany. While at HighPoint Solutions, Ruven has worked with emerging, mid-tier and large pharma on various Tendering and Contracting programs from policy and process assessments, outsourcing of business functions, software vendor evaluations and implementation of global programs. Additionally, Ruven has conducted the industry’s first Benchmarking Study on Tendering issuing 4 reports presenting the benchmarking results and developed HighPoint’s Tender Data Service THOR focusing on supporting the awareness & planning phase of Tendering while building Competitive and Pricing Intelligence. In parallel, Ruven has also worked deeply in global commercial effectiveness programs.

Fabrizio Gianfrate

Professor of Health Economics

University of Ferrara, Luiss Business School Rome, Italy

Phd and Masters in Health Economics (Rome, Stockholm, York). Master in Economic Journalism.

Full Professor of Health Economics, Market Access Consultant, Columnist. Ex-payer as AIFA member (pricing and reimbursement committee), Regional HTA Committees member (several Regions), Director at Ministry of Health (appointed), General Manager and Vice President of GSK Foundation Italy and of Angelini Foundation, several director roles in pharmaceutical industries, secondments in UK and US.

Past: Director of several magazines on healthcare and pharma, formers member of Farmindustria, Assobiotech, CENSIS, EFPIA, Federfarma.
Actual: Board Member of Italian Society of Pharmacoeconomics and Ethicals and Italian society of Healthcare studies).
Author of more than 700 articles and 7 books.

George Boretos

CMO

Cube RM

George is the CMO of Cube RM, a vendor of Revenue Management & Optimization solutions with specialization in Tender Management & CPQ software. He has more than twenty years of professional experience in managerial positions in pricing, product marketing, corporate strategy, and sales. He is also a seasoned data scientist, specializing in price optimization models, with numerous successful business forecasts and scientific publications to his name in prestigious scientific journals and publishers, such as Elsevier and Foresight. He is a member of the International Institute of Forecasters.

Sandra Garitonandía

Business Development Manager for Life Sciences

Vistex EMEA

Alejandra (Sandra) Garitonandía is the Business Development Manager for Life Sciences at Vistex EMEA. She is a Life Sciences passionate and specialized in Revenue & Margin Management for Pharma. She has a background in medical and business educational studies but also a broad experience as an IT professional. During her international career she hold different positions in business and IT in Pharma. Her specialization area is where business processes meet the IT systems and how to support efficient End-to-End Revenue Management.

Magdi Stino, MBA,MS,PhD

Product Manager

EVERSANA

Dr. Magdi Stino is a Product Manager for Eversana, Inc. and leads their efforts in aggregating data from and analyzing HTA decisions across the globe.  He earned his PhD in Health Policy from the University of the Sciences in Philadelphia as well as an MS in Health Economics and an MBA.  His post-doctoral work was for the Massachusetts Institute of Technology (MIT) Financing and Reimbursement of Cures in the US (FOCUS) project which explored financing solutions for ultra-expensive curative therapies emerging from the pipeline.  Prior to joining Eversana, he worked as a market access and health economics consultant.

Muge Gurevin

TWAL Tender & Pricing Manager

MEDTRONIC

Senior commercial process leader with 15 years of broad and multinational experience in Healthcare, IT & Telecommunications, Audit companies. Strong technical and operational background in sales, commercial & digital operations, technical product management, CRM management, project & tender management, pricing, financial analysis, business operations & intelligence, funnel and Sales Force Effectiveness and team management.

Stefan Krojer

Head of Strategic Procurement

Johanniter Competence Center GmbH

Stefan Krojer is a passionate purchaser and Head of Strategic Procurement at Johanniter Competence Center GmbH, Berlin. His career began at the hospital group Rhön-Klinikum. He gained his sales experience while working for the Group Purchasing Organization P.E.G. As a result, he was responsible for the project management for the logistics company Hospital Logiserve. As Head of Supply Chain Management at the St. Marien-Hospital Berlin he gained practical experience in the hospital procurement. With his study “Hospital Procurement 2025” published in June 2017, he is using his “Future Hospital Procurement” blog to promote transparency and dialogue between partners in hospital procurement. His specialty is digitization in hospital purchasing. He is a pioneer in social buying and social collaboration.

Antoine Jouineau

Director, Commercial Operations and Pricing

EMEA, ABBOTT RAPID DIAGNOSTICS

Antoine is currently working at Abbott as EMEA Commercial Operations and Pricing Director for the Cardiometabolic Rapid Diagnostics Division.
This role includes supervision of Tender Management, Distribution Excellence, CRM Management, Contract Management and direct involvement in Pricing Management.

Prior to Abbott, Antoine has worked for Thermo King Refrigeration for 8 years in Pricing and Commercial EMEA leadership roles.
Antoine was previously in the aerospace industry (jet engines) working with General Electric and Safran in FP&A roles of increasing responsibility.
Antoine’s education comprises of an Honours Degree in Corporate Finance, a Master of Accounting and a recent MBA from the University of Manchester.

Josh Bedel

Sr. Director Pricing and Market Access

Clovis Oncology

Josh Bedel is Senior Director for Pricing and Market Access – Europe based in Zurich, Switzerland. He brings broad experience and holistic approach to pricing and market access through various roles held across ranging functions in pharma and biotech industry such as health economics, pricing and market access, commercial effectiveness, and business IT. He is specialized in setting and executing multi-dimensional pricing strategies to drive fast market access in Europe as well as emerging markets around the world. Josh holds Bachelor’s degree in management and Economics and Master’s degree in Finance with focus on M&A in pharmaceutical industry.

TESTIMONIALS

Fresenius-Kabi SwissBioSim

Sue Caleo-Naeyaert, Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail. Anyone can benefit from this conference no matter how experienced”

Ian Tidswell

Ian Tidswell, Founder and Lead Consultant at een Consulting GmbH

The EPP Life Sciences Pricing Forum is a unique event for learning about the latest pricing challenges and techniques to address them, due to the deep experiences and skills of the participants and speakers

BTG

Giuseppe Monita , Senior Manager, Customer Services Contracts & Tendering EMEA at BTG

“Exciting & energetic meeting where it is possible to learn, share & discuss best practices and new ideas on hot topics regarding pricing & tendering” 

Cogentia Healthcare Consulting

David Alderson, Director at Cogentia Healthcare Consulting

“A good event for catching up, great networking and opportunity to share current thinking and best practice” 

Tefen Management Consulting

Chiara Garavaglia, Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

Sue Caleo-Naeyaert

Sue Caleo-Naeyaert , Global Head Pricing, Market Access and Policy Biosimilars at Fresenius-Kabi SwissBioSim

“This is a great conference which covers most pricing topics with a decent amount of detail.   Anyone can benefit from this conference no matter how experienced”

 

Henderson Azevedo

Henderson Azevedo, Global Pricing Oncology at Bayer

“A highly recommended forum for pricing professionals”

Alan Crowther

Alan Crowther, President, Global Markets at Alliance Life Sciences Consulting Group

“The 7th EPP Life Sciences Pricing Forum was the 3rd in a row that Alliance Life Sciences attended.  This year’s conference was the best yet in content. Participants come prepared to learn, share and together they helped shape the trends in our industry. The forum on the shores of Lake Geneva at the foot of the Alps is also the best locale you can imagine for a thought-provoking, content-rich conference. What a great atmosphere!”

Chiara Garavaglia

Chiara Garavaglia, Partner, Global Leader at Tefen Management Consulting

“In my experience, EEP is the only existing opportunity to discuss at 360 degrees about Pricing, involving both pharmaceutical and med tech stakeholders”

BD

, at

Baxter Healthcare

, at

Fresenius

, at

GSK

, at

Novo Nordisk

, at

Pfizer

, at

Philips Healthcare

, at

Cardinal Health

, at

Eisai

, at

Alcon

, at

Bristol-Myers Squibb

, at

Bracco Imaging

, at

Creative Ceutical

, at

Ferring

, at

Galderma

, at

GE healthcare

, at

Janssen

, at

Leica microsystems

, at

LFB

, at

Liva Nova

, at

Menarini

, at

NHS

, at

Novartis

, at

RIZIV

, at

Sanofi Aventis

, at

Shire

, at

Smith&Nephew

, at

Terumo

, at

TEVA

, at

UCB

, at

Tillots

, at

Meet pricing decision makers from:

VENUE

This year the 9th EPP Life Sciences Pricing Forum will take place in the Munich Airport Marriott Hotel.  The Munich Ariport Marriott Hotel is a beautiful venue located in a small relaxing town next to Munich.  The hotel is just a few minutes away from the airport and can be easily reached by a shuttle bus.

 

Address: Alois Steinecker Strasse 20, Freising 85354 Germany

 

CONTENT

Outcome-based pricing initiatives in the healthcare industry

A distorted reimbursement model has driven healthcare costs ever higher, and elevated healthcare spend to the top budget item for many governments across the globe. But several major industry players have begun to experiment with outcome-based pricing models as an innovative approach to align reimbursements more closely with positive outcomes, while simultaneously bringing greater stability and predictability to pricing in the life science industry.
This paper evaluates the current state of reimbursement models, the adjustments that need to be considered, and methods for reform while offering practical alternatives for both outcome-based pricing and payment methods for all stakeholders in the value chain.

The Evolving Landscape of biosimilars and its impact on the public procurement and tendering environment

Highpoint, an IQVIA company, has conducted various analysis to assess the impact of tenders for biosimilars and observed recent market trends as well as manufacturer behaviors to capture the subtle changes. Our findings translate into a comprehensive view on how companies could improve their bidding and tender strategy to succeed in this space. lastly, we provide our outlook on this topic emphasizing the importance for all stakeholders to find the right balance between cost containment for payers and sustainability for manufacturers to ensure that ultimately, patients and physicians will have multiple treatment options available.

Download your content here !

We hope you enjoy the content.

Get Brochure Get Brochure

EPP PARTNERSHIPS

For more info please contact Britt.dejager@pricingplatform.eu

REGISTRATION

. EPP Members benefit from our preferred membership rates – contact Britt Dejager
. Not yet a member ? Discover all EPP member benefits here 
• Once a registration is completed, tickets are transferable but never refundable. This applies to payments after invoice as well.

SAVE MONEY WITH THE SUPER EARLY BIRD TICKETS! VALID UNITL AUGUST 31st!

FULL CONFERENCE PASS

1795
Early Bird
YOU JUST SAVED € 200
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event

BUY 2 GET 1 FREE

3990
SAVE €1995 WITH THIS PASS
 
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event

BUY 3 GET 2 FREE

5989
SAVE € 3390 WITH THIS PASS
 
Access to workshops
Access to 2 forum days
Access to evening event
PDF presentations after event

FORUM PASS ONLY

1495
Early Bird
YOU JUST SAVED €200
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event

BUY 2 GET 1 FREE

3390
SAVE €1695 WITH THIS PASS
 
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event

BUY 3 GET 2 FREE

5085
SAVE € 3390 WITH THIS PASS
 
 
Access to 2 forum days
Access to evening event Oct 15th
PDF presentations after event

PRE FORUM WORKSHOP ONLY

695
Access to pre-forum workshop only

Group discounts are available of > 3 people
Inquire

EXPERT FORUM PASS

2995
15-16 OCT
Access to the 2 forum days
Access to evening event
PDF presentations after event

GROUP RATES

on demand
Group discounts of > 2 people